Ardelyx Inc

ARDX is in a pronounced Stage 4 downtrend, trading below all major EMAs with a clear lower-highs/lower-lows sequence. Medium-term bias is bearish, favoring selling rallies into the EMA9/20 resistance zone rather than initiating new positions at extreme lows. Short-term conditions remain unfavorable for selling into support near its 52-week low, so patience is warranted for bounce rejections around $4.06–4.21. Execution should focus on disciplined rejection at resistance levels.

• ↑Q2 2026 product revenue $118.1M (+31% YoY), IBSRELA $86.2M (+33% YoY).
• ↑Cash & equivalents of $281.8M support R&D and operations.
• ↓ROE of -39% highlights weak profitability and capital inefficiency.